Cryptosporidiosis: environmental, therapeutic, and preventive challenges

September 27, 2010 at 11:44 pm Leave a comment

Europ J of Clinical Microb & Infec Dis  August 2010 V.29  N.8  p.927 – 935

 S. Collinet-Adler1, 2, 3  and H. D. Ward1, 2

 (1) Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA, USA

(2) Tufts University, Boston, MA, USA

(3) Tufts Medical Center, Box #41, 800, Washington Street, Boston, MA 02111, USA


Cryptosporidium spp. are responsible for endemic and epidemic disease worldwide. Clinical manifestations may include acute, persistent, or chronic diarrhea, biliary, and pulmonary disease. Disease severity ranges from asymptomatic or mild to severe, intractable diarrhea with wasting depending on immune status, nutrition, and age. Transmission is fecal–oral with both human and animal reservoirs. Disease is often self limited in healthy individuals, but therapy remains a challenge in the immune-compromised. Prevention currently depends on appropriate hygiene and proper water management and treatment.


Entry filed under: Antiparasitarios, Epidemiología, Infecciones parasitarias.

Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study. Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


September 2010

Most Recent Posts

%d bloggers like this: